These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31917795)

  • 1. Soluble AXL as a marker of disease progression and survival in melanoma.
    Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
    PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
    Johansson G; Peng PC; Huang PY; Chien HF; Hua KT; Kuo ML; Chen CT; Lee MJ
    PLoS One; 2014; 9(12):e115916. PubMed ID: 25551830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
    Raymond D; Fukui M; Zwernik S; Kassam A; Rovin R; Akhtar P
    PLoS One; 2024; 19(7):e0301739. PubMed ID: 38968207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
    Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
    Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
    Ekman C; Stenhoff J; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AXL receptor tyrosine kinase is increased in patients with heart failure.
    Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
    Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axl is related to inflammation in hemodialysis patients.
    Li M; Xue W; Li X; Song Y; Liu X; Qin L
    Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
    Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
    Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
    Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
    Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
    Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma.
    Bae CA; Ham IH; Oh HJ; Lee D; Woo J; Son SY; Yoon JH; Lorens JB; Brekken RA; Kim TM; Han SU; Park WS; Hur H
    Gastric Cancer; 2020 Sep; 23(5):824-836. PubMed ID: 32239298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
    von Mässenhausen A; Brägelmann J; Billig H; Thewes B; Queisser A; Vogel W; Kristiansen G; Schröck A; Bootz F; Brossart P; Kirfel J; Perner S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
    Ekman C; Gottsäter A; Lindblad B; Dahlbäck B
    Clin Biochem; 2010 Jul; 43(10-11):873-6. PubMed ID: 20417630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
    Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Grönwall C; Mohan C; Gunnarsson I
    PLoS One; 2019; 14(2):e0212068. PubMed ID: 30742665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
    Ekman C; Linder A; Akesson P; Dahlbäck B
    Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble AXL is ubiquitously present in malignant serous effusions.
    Flem Karlsen K; McFadden E; Flørenes VA; Davidson B
    Gynecol Oncol; 2019 Feb; 152(2):408-415. PubMed ID: 30448261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.